Literature DB >> 31784757

Hepatitis C Virus Infection of Human Thyrocytes: Metabolic, Hormonal, and Immunological Implications.

Sara Salehi Hammerstad1, Jason T Blackard2, Angela Lombardi3, Randall P Owen4, Erlinda Concepcion3, Zhengzi Yi5, Weijia Zhang5, Yaron Tomer3.   

Abstract

CONTEXT: Hepatitis C virus (HCV) infection is a prevalent disease worldwide. Thyroid dysfunction is one of the most common extrahepatic manifestations of HCV infection. We hypothesized that HCV can directly infect human thyrocytes thereby causing thyroid dysfunction.
SETTING: Human thyrocytes in primary cell culture, ML-1 human thyroid cell line, and Huh7.5 human hepatocyte cell line were infected with HCV using the Huh7.5JFH1 cell line that releases infectious HCV virions. After infection, the release of new virions, production of proinflammatory cytokines, and expression of miR-122 were evaluated. Ribonucleic acid (RNA) extracted from HCV-infected cells and mock-infected cells was subjected to RNA sequencing and transcriptomic analysis. Ingenuity pathway analysis was used to detect up- and down-regulated pathways.
RESULTS: Human thyrocytes express major HCV entry factors including CD81, occludin, claudin-1, and scavenger receptor class B1. Viral infection of thyroid cells was confirmed by detection of HCV core protein in supernatants and negative-sense HCV RNA in cell lysates. HCV infection of thyrocytes induced the production of the chemokine CXCL-8 and the proinflammatory cytokines tumor necrosis factor alpha (TNF-α) and significantly increased the expression of miR-122. Moreover, HCV infection of thyrocytes decreased expression of the thyroid peroxidase and thyroglobulin genes and increased expression of the deiodinase 2 gene. The top upregulated pathways in HCV-infected thyrocytes were immune pathways and metabolic pathways, while infected hepatocytes upregulated lipid and glucose metabolism pathways as previously reported.
CONCLUSIONS: HCV infection may induce thyroid dysfunction by different mechanisms including direct infection of thyrocytes leading to activation of inflammatory pathways and upregulation of miR-122. These findings support a general mechanism for viral induction of autoimmunity through direct infection of target tissues. © Endocrine Society 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  IL-8; RNA sequencing; cytokine; hepatitis C virus; miR-122; thyroiditis autoimmune

Year:  2020        PMID: 31784757      PMCID: PMC7067536          DOI: 10.1210/clinem/dgz241

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  37 in total

1.  Establishment and characterization of the follicular thyroid carcinoma cell line ML-1.

Authors:  J Schönberger; J Bauer; T Spruss; G Weber; I Chahoud; C Eilles; D Grimm
Journal:  J Mol Med (Berl)       Date:  2000       Impact factor: 4.599

Review 2.  A tale of two strands: reverse-transcriptase polymerase chain reaction detection of hepatitis C virus replication.

Authors:  D V Sangar; A R Carroll
Journal:  Hepatology       Date:  1998-11       Impact factor: 17.425

3.  [Prevalence of extra-hepatic manifestations in infection with hepatitis C virus: study of 140 cases].

Authors:  A Kahloun; T Babba; B Fathallah; M Ghozzi; H Ezzine; Y Said; M M Azzouz
Journal:  Tunis Med       Date:  2011-06

4.  IFN-α mediates the development of autoimmunity both by direct tissue toxicity and through immune cell recruitment mechanisms.

Authors:  Nagako Akeno; Eric P Smith; Mihaela Stefan; Amanda K Huber; Weijia Zhang; Mehdi Keddache; Yaron Tomer
Journal:  J Immunol       Date:  2011-03-14       Impact factor: 5.422

5.  Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor.

Authors:  Birke Bartosch; Alessandra Vitelli; Christelle Granier; Caroline Goujon; Jean Dubuisson; Simona Pascale; Elisa Scarselli; Riccardo Cortese; Alfredo Nicosia; François-Loïc Cosset
Journal:  J Biol Chem       Date:  2003-08-11       Impact factor: 5.157

6.  CD81 is required for hepatitis C virus glycoprotein-mediated viral infection.

Authors:  Jie Zhang; Glenn Randall; Adrian Higginbottom; Peter Monk; Charles M Rice; Jane A McKeating
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

Review 7.  Toxic chemicals and thyroid function: hard facts and lateral thinking.

Authors:  Leonidas H Duntas; Nikos Stathatos
Journal:  Rev Endocr Metab Disord       Date:  2015-12       Impact factor: 6.514

8.  Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry.

Authors:  Matthew J Evans; Thomas von Hahn; Donna M Tscherne; Andrew J Syder; Maryline Panis; Benno Wölk; Theodora Hatziioannou; Jane A McKeating; Paul D Bieniasz; Charles M Rice
Journal:  Nature       Date:  2007-02-25       Impact factor: 49.962

9.  Transcriptome sequencing, microarray, and proteomic analyses reveal cellular and metabolic impact of hepatitis C virus infection in vitro.

Authors:  Stephen D Woodhouse; Ramamurthy Narayan; Sally Latham; Sheena Lee; Robin Antrobus; Bevin Gangadharan; Shujun Luo; Gary P Schroth; Paul Klenerman; Nicole Zitzmann
Journal:  Hepatology       Date:  2010-08       Impact factor: 17.425

10.  Hepatitis C virus genetics affects miR-122 requirements and response to miR-122 inhibitors.

Authors:  Benjamin Israelow; Gavriel Mullokandov; Judith Agudo; Marion Sourisseau; Ali Bashir; Andres Y Maldonado; Arvin C Dar; Brian D Brown; Matthew J Evans
Journal:  Nat Commun       Date:  2014-11-18       Impact factor: 14.919

View more
  3 in total

1.  High Prevalence of Common Human Viruses in Thyroid Tissue.

Authors:  Therese Weider; Angelo Genoni; Francesco Broccolo; Trond H Paulsen; Knut Dahl-Jørgensen; Antonio Toniolo; Sara Salehi Hammerstad
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-14       Impact factor: 6.055

2.  Assessing State Variation in Plastic Surgeons' Risk of Hepatitis C Exposure: Revisit in Methodology.

Authors:  Kristen M Hardy; Cody L Mullens; Aaron C Mason
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-10-27

3.  HLA Class I Upregulation and Antiviral Immune Responses in Graves Disease.

Authors:  Therese Weider; Sarah J Richardson; Noel G Morgan; Trond H Paulsen; Knut Dahl-Jørgensen; Sara Salehi Hammerstad
Journal:  J Clin Endocrinol Metab       Date:  2021-03-25       Impact factor: 5.958

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.